{"id":700215,"date":"2020-05-15T09:00:00","date_gmt":"2020-05-15T09:00:00","guid":{"rendered":"https:\/\/www.pm360online.com\/?guid=6dded870bbc12ca84197a03cc656d372"},"modified":"2020-05-15T09:00:00","modified_gmt":"2020-05-15T09:00:00","slug":"affimed-announces-abstracts-on-innate-cell-engagers-from-its-rock-platform-accepted-for-presentation-at-aacr-virtual-annual-meeting-ii","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/affimed-announces-abstracts-on-innate-cell-engagers-from-its-rock-platform-accepted-for-presentation-at-aacr-virtual-annual-meeting-ii\/","title":{"rendered":"Affimed Announces Abstracts on Innate Cell Engagers from its ROCK\u00ae Platform Accepted for Presentation at AACR Virtual Annual Meeting II"},"content":{"rendered":"<p><![CDATA[Heidelberg, Germany, May 15, 2020 \u2013\u00a0Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that data from two studies investigating innate cell engagers developed from its fit-for-purpose ROCK\u00ae platform have been accepted for e-poster presentations at the American Association for Cancer Research (AACR) Virtual Annual Meeting II being held on June 22-24, 2020. Affimed researchers served as authors on abstract #5659 and co-authors on abstract #6987 with scientific collaborators from Genentech, a member of the Roche Group, on the respective abstracts that include the following:]]><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":74553,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71350,71360],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/700215"}],"collection":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/users\/74553"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/comments?post=700215"}],"version-history":[{"count":0,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/700215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media?parent=700215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/categories?post=700215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/tags?post=700215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}